§ Funding Round
Series C funding round for Endeavor BioMedicines raising $130M in April 2024
Series C funding round for Endeavor BioMedicines raising $130M in April 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Omega Funds | — | — |
RA Capital | — | — |
| Organization | — | |
| Organization | — | |
Ally Bridge Group | — | — |
| Organization | — | |
ayurmayaLEAD | Organization | — |
| Organization | — | |
karan takharLEAD | Angel | karan takhar |
Fidelity Management & Research Company | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Piper Heartland Healthcare Capital | — | — |
Silver Arch Bio | — | — |
| Organization | — | |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$292M
Top Valuation
-
Endeavor BioMedicines raised $130M in a Series C round.
The round was announced on 04/01/24.
The round was led by ayurmaya, karan takhar.
